Journal of Prostate Cancer
黑料网
Abiraterone Acetate
Search results for
Abiraterone Acetate
Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 黑料网 Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
黑料网 Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Indexed In
- RefSeek
- Hamdard University
- EBSCO A-Z
- Publons
Useful Links
Related Subjects
Share This Page
Abiraterone Acetate
Abiraterone acetate is a type of hormone therapy, classified as an “adrenal inhibitor". It is indicated for use in combination with prednisone for the treatment of men with metastatic castration-resistant prostate cancer who have already received prior chemotherapy containing docetaxel.
Adverse effect: Hypertension: Abiraterone may cause an increase in blood pressure, Urinary tract infection: Cloudy or smelly urine, pain or discomfort when passing urine, Diarrhea : Drink plenty of fluids if you have diarrhea at least 2 litres (about 3 pints) a day.
Related Journals of Abiraterone Acetate
Journal of Prostate Cancer, Journal of Cancer Science & Therapy, The Lancet Oncology, Prostate Cancer Learning Hub, journal of clinical oncology, European society for medical oncology
Abiraterone Acetate
Speaker PPTs
- Thomas Ryzlewicz
Problems of calcification in dialysis fluid with acidification of 3 mmol/l Acetate
| PDF Version - Kanchana Usuwanthim
An ethyl acetate fraction of moringa oleifera lam. inhibhits human macrophage cytokine production induced by cigarette smoke
| PDF Version